Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when AN2 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANTX alerts

About Joshua Eizen

Joshua Eizen is recorded as General Counsel at AN2 Therapeutics, Inc. (ANTX) since November 4, 2024 and COO at AN2 Therapeutics, Inc. (ANTX). The newest filing on record that lists Joshua Eizen as COO at AN2 Therapeutics, Inc. (ANTX) is dated April 22, 2026. AN2 Therapeutics, Inc. reported in an 8-K filed November 5, 2024 that Joshua Eizen was appointed Chief Legal Officer and Chief Operating Officer, effective November 4, 2024. The proxy statement of AN2 Therapeutics, Inc. reports total compensation of $1,354,563 for Joshua Eizen in fiscal 2022, including a base salary of $101,742. AN2 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AN2 Therapeutics, Inc. includes Eric Easom (CEO and Board Member), Lucy Day (CFO and Chief Accounting Officer), Josh Eizen (COO) and 7 others.

“On November 4, 2024, the Board of Directors of AN2 Therapeutics, Inc. (the "Company") appointed Joshua Eizen, the Company's current Chief Legal Counsel, age 47, as Chief Legal Officer and Chief Operating Officer of the Company, effective immediately (the "Effective Date").”
AN2 Therapeutics, Inc. Form 8-K, filed November 5, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at AN2 Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 AN2 Therapeutics, Inc. (ANTX) $101,742 $1,354,563

Recent activity